OHIO HEMATOLOGY ONCOLOGY SOCIETY (EIN 311304908) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

MICHELLE WEISS

Phone

6147212551

Tax Period

2025-01-01 to 2025-12-31

OHIO HEMATOLOGY ONCOLOGY SOCIETY, founded in 1994, is a small nonprofit that reported $516K in total revenue in fiscal year 2025. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $166K, a strong 32% operating margin.

Mission

PROMOTION OF PROFESSIONAL STANDARDS IN FIELD OF HEMATOLOGY AND ONCOLOGY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $501,997

Program Service Revenue $0

Investment Income $13,915

Other Revenue $0

TOTAL REVENUE $515,912

Expense Breakdown

Grants Paid $0

Salaries & Benefits $216,680

Fundraising Expenses $0

Other Expenses $132,854

TOTAL EXPENSES $349,534

Year-over-Year Comparison

	2025	2024	Change
Revenue	$515,912	$394,056	+0.3%
Expenses	$349,534	$326,839	+0.1%
Net Income	$166,378	$67,217	+1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$183,902

Total Directors

$183,902

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHELLE WEISS	EXECUTIVE DIRECTOR	40.00	Officer Director	$183,902	$0	$183,902
SLOBODAN STANISIC	PRESIDENT	2.00	Director	$0	$0	$0
CHARLES BANE	VICE PRESIDENT	2.00	Director	$0	$0	$0
SHABANA DEWANI	TRUSTEE	2.00	Director	$0	$0	$0
RAZA KHAN	TRUSTEE	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$515,912	$349,534	$558,752	$166,378
2024	$394,056	$326,839	$392,374	$67,217
2023	$276,244	$308,557	$325,157	$-32,313
2022	$269,866	$321,235	$357,470	$-51,369
2021	$268,224	$296,162	$408,839	$-27,938
2020	$283,729	$266,307	$436,777	$17,422
2019	$270,573	$292,997	$419,355	$-22,424
2018	$286,629	$290,955	$441,779	$-4,326

OHIO HEMATOLOGY ONCOLOGY SOCIETY